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The Parkinson’s disease factors PINK1 and parkin are strongly implicated in stress-induced mitophagy in vitro, but little 
is known about their impact on basal mitophagy in vivo. We generated transgenic Drosophila melanogaster expressing 
fluorescent mitophagy reporters to evaluate the impact of Pink1/parkin mutations on basal mitophagy under physiological 
conditions. We find that mitophagy is readily detectable and abundant in many tissues, including Parkinson’s disease–
relevant dopaminergic neurons. However, we did not detect mitolysosomes in flight muscle. Surprisingly, in Pink1 or parkin 
null flies, we did not observe any substantial impact on basal mitophagy. Because these flies exhibit locomotor defects and 
dopaminergic neuron loss, our findings raise questions about current assumptions of the pathogenic mechanism associated 
with the PINK1/parkin pathway. Our findings provide evidence that Pink1 and parkin are not essential for bulk basal 
mitophagy in Drosophila. They also emphasize that mechanisms underpinning basal mitophagy remain largely obscure.
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Introduction
Mitochondria are essential organelles that perform many crit-
ical metabolic functions but are also a major source of damag-
ing reactive oxygen species and harbor proapoptotic factors. 
Multiple homeostatic processes operate to maintain mito-
chondrial integrity; however, terminally damaged organelles 
are degraded through the process of targeted mitochondrial 
autophagy (mitophagy) to prevent potentially catastrophic 
consequences. Such homeostatic mechanisms are particularly 
important for postmitotic, energetically demanding tissues 
such as nerves and muscles. Two proteins linked to Parkinson’s 
disease (PD), parkin, a cytosolic ubiquitin E3 ligase, and PINK1, 
a mitochondrially targeted kinase, have been shown to play key 
roles in mitophagy.
PINK1/Parkin-mediated mitophagy has been intensively 
investigated, and many of the molecular mechanisms have been 
elucidated (Pickrell and Youle, 2015; Yamano et al., 2016). In 
brief, upon loss of mitochondrial membrane potential as occurs 
in damaged or dysfunctional mitochondria, PINK1 accumulates 
on the outer mitochondrial membrane (OMM) and initiates the 
mitophagy signal by phosphorylating both ubiquitin and parkin. 
This promotes parkin’s E3-ligase activity, thereby depositing 
more ubiquitin for subsequent phosphorylation. This process 
acts as a feed-forward mechanism ultimately decorating the 
OMM with phosphoubiquitin chains that are then recognized 
by ubiquitin adaptor proteins leading to the engulfment of the 
depolarized mitochondria by autophagosomes.
As a pathogenic mechanism, failure in mitophagy offers an 
attractive explanation for multiple, longstanding observations 
that implicate mitochondrial defects in the pathogenicity of PD, 
such as systemic mitochondrial complex I deficits and high lev-
els of mitochondrial DNA mutations in PD patients (Schapira et 
al., 1989; Bender et al., 2006; Kraytsberg et al., 2006; Exner et 
al., 2012; Dias et al., 2013). In addition, the unique physiological 
characteristics of substantia nigra neurons, such as their exten-
sive arborization, myriad synaptic connections, and continuous 
pacemaking activity, place an extreme demand on mitochon-
drial function to meet their high energy and calcium buffering 
requirements. This may explain the selective vulnerability of 
these neurons to loss of mitochondrial integrity (Sulzer and 
Surmeier, 2013).
Many of the molecular details of PINK1/parkin-induced mito-
phagy have been elaborated in cultured cells that overexpress 
parkin coupled with acute mitochondrial depolarization or toxi-
fication (Pickrell and Youle, 2015; Yamano et al., 2016). However, 
relatively little is known about mitophagy under physiological 
conditions in vivo (Cummins and Gotz, 2017; Rodger et al., 2017; 
Whitworth and Pallanck, 2017). One of the limitations to study-
ing mitophagy in vivo has been the paucity of suitable reporters. 
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Recently, two in vivo mitophagy reporter models have been 
described in mice (Sun et al., 2015; McWilliams et al., 2016). One 
uses a mitochondrial matrix–targeted pH-sensitive variant of 
GFP (mt-Keima), whereas the other uses a tandem GFP-mCherry 
fusion protein targeted to the OMM (called mito-QC). Both sys-
tems exploit pH-sensitive properties of mKeima and GFP, respec-
tively, to enable the differential labeling of mitochondria in the 
acidic microenvironment of the lysosome as a proxy endpoint 
readout. Initial studies on these two reporter lines have revealed 
a surprisingly widespread and heterogeneous distribution of 
basal mitophagy, but the involvement of PINK1 and parkin has 
not been addressed.
We have generated Drosophila melanogaster lines expressing 
these mitophagy reporters to provide the first global view of the 
prevalence of mitophagy across the organism and to determine 
the relative contribution of Pink1 and parkin to basal mitophagy. 
Analyzing mitophagy in Drosophila offers a valuable opportunity 
to interrogate the physiological requirement of Pink1/parkin in 
this process in vivo. In contrast to most mammalian models, loss 
of Drosophila Pink1 or parkin leads to robust phenotypes in loco-
motor activity and dopaminergic (DA) neuron loss (Greene et al., 
2003; Clark et al., 2006; Park et al., 2006), indicating their crit-
ical function in the related neuromuscular tissues. We find that 
although basal mitophagy is widespread in many tissues in Dro-
sophila, the incidence of mitolysosomes, and hence, basal mito-
phagy, is unaffected by loss of Pink1 or parkin. Moreover, flight 
muscle, which shows the most robust disruption upon Pink1/
parkin mutation (Greene et al., 2003, 2005; Clark et al., 2006; 
Park et al., 2006), does not reveal a detectable mitophagy signal. 
Hence, we propose that Pink1 and parkin are largely dispensable 
for basal mitophagy and have mitophagy-independent functions 
in neuromuscular tissues in Drosophila.
Results and discussion
Validation of mitophagy reporters in Drosophila
We first generated GAL4/UAS-inducible transgenic lines to 
express either mito-QC or mt-Keima. Multiple lines were estab-
lished and immunoblotting confirmed comparable expression 
between lines (Fig. S1, A and B). Expression of these reporters in 
all lines appeared benign and did not noticeably affect develop-
ment or viability. To ensure that the expression of these reporters 
did not overtly interfere with normal cellular functions in vivo, 
particularly in the sensitive neuromuscular systems of interest 
here, we analyzed locomotor activity in flies expressing high lev-
els of the mito-QC or mt-Keima in all tissues and observed no 
significant impact (Fig. S1, C–F).
Previous work has demonstrated the appropriate targeting of 
mito-QC and mt-Keima to mitochondria in vitro and in vivo, and 
that “spectral shifted” puncta of more acidic conditions indeed 
colocalized with lysosomes (Katayama et al., 2011; Allen et al., 
2013). Nevertheless, we also sought to verify these conditions 
in our Drosophila lines. As expected, we observed substantial 
colocalization of mito-QC and mt-Keima with the mitochondrial 
protein ATP5A in two tissues highly amenable for mitochon-
drial imaging analysis, larval epidermal cells and adult flight 
muscle (Fig. 1, A–C). Interestingly, the outer membrane targeted 
mito-QC shows a nonuniform distribution across the network in 
epidermal cells, which reflects the dynamic and heterogeneous 
nature of the mitochondrial network. In contrast, the matrix 
localized mt-Keima more precisely colocalizes with ATP5A 
immunostaining.
The spectral shift that marks mitolysosomes of mito-QC 
occurs by the selective quenching of GFP, but not mCherry, 
resulting in “red-only” puncta (Fig. 1 D). Similarly, for mt-Keima, 
the fluorescence spectrum shifts to reflect an increased signal 
from excitation at 561 nm when under more acidic conditions 
(Fig. 1 E). With both mitophagy reporters, we observed a strik-
ing colocalization of “mitophagy” puncta with LysoTracker 
(Fig. 1, D and E).
To further validate these puncta as mitolysosomes, we 
assessed their formation in tissue lacking the canonical auto-
phagy pathway generated by knockdown of the key autophagy 
factor Atg5. Mitolysosome signal reported by both mito-QC and 
mt-Keima were significantly reduced in Atg5-RNAi epidermal 
cells (Fig. 1, F and G), consistent with their appearance reflect-
ing mitophagy. Moreover, we sought to demonstrate that these 
reporters were sensitive enough to reveal induced mitophagy. 
Although sustained treatment with mitochondrial depolarizing 
agents, such as carbonyl cyanide 3-chlorophenylhydrazone, was 
not feasible in vivo, it was previously reported that iron chelation 
by deferiprone induced mitophagy reported by mito-QC (Allen et 
al., 2013). Feeding animals deferiprone, we observed an increase 
in mitolysosomes reported by mito-QC and mt-Keima (Fig. 1, F 
and H). Collectively, these findings validate the mitophagy signal 
of mito-QC and mt-Keima as faithful reporters of mitolysosomes 
in Drosophila, similarly to previously characterized mouse mod-
els (Sun et al., 2015; McWilliams et al., 2016).
Mitophagy is widespread in multiple Drosophila tissues
We next determined the prevalence of mitolysosomes under 
basal conditions in multiple tissues. In larvae, we analyzed 
epidermal cells, because they have an elaborate mitochondrial 
morphology, and the ventral ganglion, a major portion of the 
central nervous system (CNS). Here, we directly compared the 
mitolysosome signal reported by mito-QC and mt-Keima. Micro-
scopic analysis revealed that mitolysosomes are abundant under 
basal conditions in both epidermal cells and CNS (Fig. 2, A–D). 
In contrast, mitolysosomes were almost undetectable in larval 
body wall muscles (unpublished data). Importantly, mito-QC and 
mt-Keima revealed a very similar abundance and distribution of 
mitolysosomes, substantiating their utility as equivalent mito-
phagy reporters.
During this stage of analysis, we found that the mt-Keima 
signal, which was already markedly weaker than that generated 
by mito-QC, was rapidly bleached upon extended exposure or 
repeated scanning. Repeated imaging was necessary to achieve 
adequate penetration into complex tissue and for z-stack (3D) 
reconstruction for mitolysosome quantification. For this reason, 
the subsequent analyses mainly focused on analyzing mito-QC.
We next analyzed adult tissues where postmitotic, highly 
energetic tissues would be expected to accumulate more mito-
chondrial damage and therefore likely undergo more mitoph-
agy. Again, we observed abundant mitolysosomes, widespread 
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Figure 1. Validation of mito-QC and mt-Keima mitophagy reporters. (A–C) Immunohistochemical and confocal imaging analysis of larval epidermal cells 
(A and C) and adult flight muscle (B). (A and B) Native GFP fluorescence (green) and (C) 458-nm-stimulated fluorescence (neutral pH) were compared with a 
mitochondrial protein distribution by immunostaining with anti-ATP5A (magenta). (D and E) Confocal live imaging analysis of larval epidermal cells for mito-QC 
(D) and mt-Keima (E) neutral and acidic pH spectra costained for LysoTracker to mark lysosomes. Fluorescence corresponding to neutral pH and acidic pH are 
shown in green and red, respectively. LysoTracker is shown in white. (F) Quantification of mitolysosomes in mito-QC larval epidermal cells shown in G and 
H. Chart shows mean ± SD of n = 6 animals for (WT) control, n = 2 animals for deferiprone and Atg5-RNAi expression. Number of cells analyzed: epidermis, 
WT = 29 cells, deferiprone and Atg5-RNAi = 14 cells each. Statistical significance determined by one-way ANO VA with Sidak’s post-hoc test; ***, P < 0.001; 
****, P < 0.0001. (G and H) Confocal imaging analysis of larval epidermal cells for mito-QC and mt-Keima upon expression of an Atg5-RNAi transgene to inhibit 
autophagy (G) or exposure to the iron chelator deferiprone (65 µM) to induce mitophagy (H). Bars: (A, top; and B, D, E, G, and H) 10 µm; (A, bottom; and C) 
4 µm. Genotypes analyzed were da-GAL4/UAS-mito-QC (A, D, and H), Mef2-GAL4/UAS-mito-QC (B), tub-GAL4, UAS-mt-Keima (C, E, and H), and da-GAL4, 
UAS-mito-QC/UAS-Atg5-RNAi and tub-GAL4, UAS-mt-Keima/UAS-Atg5-RNAi (G).
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in a medial region of the posterior protocerebrum (adult brain; 
Fig. 3). PD is associated with the preferential degeneration of DA 
neurons, which is reproduced in multiple Drosophila models of 
PD, including by cell-autonomous loss of Pink1/parkin (Hewitt 
and Whitworth, 2017). Mito-QC was selectively expressed in DA 
neurons via the tyrosine hydroxylase (TH) GAL4 driver. Analyz-
ing the PPL1 cluster, which has most consistently been shown to 
be affected in Pink1/parkin mutants, we observed a substantial 
mitophagy signal in DA neurons (Fig. 3). The amount of mitoph-
agy signal did not markedly increase with ageing.
Somewhat surprisingly, but consistent with observations in 
larvae, we did not observe any appreciable mitolysosomes in 2-d-
old flight muscle (Fig. 3). This is notable for two reasons. First, 
adult flight muscle in particular has extremely abundant mito-
chondria necessary to power flight. Second, Pink1 and parkin 
mutant Drosophila display robust degeneration of flight muscles. 
It could be reasonably assumed that this degeneration results 
from a failure in mitophagy induction. The lack of mitophagy 
signal is especially surprising given the abundant mitochondria 
and apparent abundant lysosomes in this tissue (Demontis and 
Perrimon, 2010).
We reasoned that analyzing adult tissue could possibly have 
missed a critical period when mitophagy is active and required 
for muscle integrity, such as when the tissue is being formed in 
development. To address this, we analyzed flight muscle of the 
pupal stage when disruption of muscle integrity first occurs in 
Figure 2. Comparison of mito-QC and 
mt-Keima mitophagy reporters in larval tis-
sues. (A–D) Confocal microscopy analysis of 
larval epidermal cells (A and B) and the ven-
tral ganglion of the CNS (C and D), visualizing 
mito-QC (fixed) and mt-Keima (live) as indicated. 
Fluorescence corresponding to neutral pH and 
acidic pH are shown in green and red, respec-
tively. Genotypes analyzed were da-GAL4/UAS-
mito-QC (A and C) and tub-GAL4, UAS-mt-Keima 
(B and D). Bars, 10 µm.
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Pink1/parkin mutants (Greene et al., 2005; Clark et al., 2006). 
However, we also could not detect mitolysosomes at these earlier 
time points (Fig. 3). Collectively, from these observations, we sur-
mise that mitophagy is abundant in various tissues during devel-
opment and in adult flies, especially in neuronal tissue, but is not 
detectable in muscle tissue at either stage.
Pink1 and parkin are largely dispensable for basal 
mitophagy in Drosophila
Mammalian PINK1 and parkin have been described to play 
important roles in toxin-induced mitophagy; however, the 
impact of PINK1 and parkin on basal mitophagy in vivo has not 
been extensively studied. To address this, we combined our 
mitophagy reporters with well-characterized Pink1 and parkin 
Drosophila mutants. Analyzing the previously described tissues 
where mitolysosomes were abundant, we found that mitophagy 
was not dramatically reduced in genetic null mutants for Pink1 
(Fig. 4) or parkin (Fig. 5). To quantify the degree of mitophagy 
we applied a semiautomated quantification analysis to segment 
3D images to identify and quantify bona fide mitolysosomes (Fig. 
S2). Quantitative analyses revealed there was no statistical dif-
ference in number of mitolysosomes between WT and Pink1 or 
parkin mutant animals for most cell types, except for larval CNS, 
where the difference in Pink1 mutants just reached significance 
(Figs. 4 and 5). To further verify this unexpected lack of effect, we 
qualitatively assessed mt-Keima in Pink1 mutants, and we also 
observed no gross difference in mitophagy signal (Fig. S3).
Finally, although mitolysosomes were not detectable in WT 
flight muscle, we considered that because profound mitochon-
drial disruption occurs in flight muscle of Pink1/parkin mutants, 
mitophagy may be induced as a homeostatic response. How-
ever, we again observed no mitophagy signal in Pink1 or parkin 
mutants (Figs. 4 and 5). Thus, collectively these data indicate 
that loss of Pink1 or parkin does not substantially influence basal 
mitophagy in neuromuscular tissues.
The notion that PINK1 and parkin cooperate to mediate bulk 
degradation of mitochondria has become a dominant concept 
in the field of PD pathogenesis. Although a large body of work 
has elucidated the molecular details of PINK1/parkin-mediated 
stress-induced mitophagy in vitro, it has been an open question 
whether PINK1 and parkin perform equivalent functions under 
physiological conditions (Cummins and Gotz, 2017; Rodger et al., 
2017; Whitworth and Pallanck, 2017). We have made use of two 
previously devised mitophagy reporter constructs to visualize 
mitophagy in fly models for the first time. Our observations reveal 
that basal mitophagy is highly prevalent in multiple Drosophila 
tissues; however, this mitophagic process is essentially unaffected 
by null mutations in Pink1 or parkin. Importantly, while this work 
was under review, a complementary study was published report-
ing the effect on the mito-QC reporter system in Pink1 knockout 
mice (McWilliams et al., 2018). This study reached essentially the 
same conclusion as our study that basal mitophagy is unaffected by 
loss of PINK1 in most tissues. Together, our complementary studies 
analyzing independent mitophagy reporters in multiple mutant 
models provide strong evidence that the minimal impact of PINK1 
and parkin on basal mitophagy is likely a conserved phenomenon.
The simplest interpretation of these results is that PINK1 and 
parkin do not in fact play an important role in basal mitophagy; 
however, this seems unlikely given the plethora of evidence sup-
porting PINK1/parkin in some form of mitochondrial degrada-
tion. Several alternative explanations can be considered. One clear 
possibility is that another mode of mitophagy can be induced as a 
compensatory mechanism. Indeed, there is some precedence for 
this as it was recently reported that MUL1 acts redundantly along-
side parkin (Yun et al., 2014; Rojansky et al., 2016). Other ubiquitin 
ligases have also been implicated in mitophagy, such as ARIH1/
HHA RI (Villa et al., 2017). Moreover, although germline knockout 
of murine PINK1 and parkin has been shown to have very mild 
phenotypes (Lee et al., 2012), conditional postnatal loss of PINK1 
Figure 3. Mitolysosome analysis with mito-QC in adult tissues. Confocal 
microscopy analysis of mito-QC reporter in WT adult brain (2 d old), DA neu-
rons at 2 and 30 d old, flight muscle (2 d old), and preadult (pupal) flight mus-
cle, as indicated. Mitolysosomes are evident as GFP-negative/mCherry-pos-
itive (red-only) puncta. Quantification of mitolysosomes is shown in Figs. 4 
and 5. Genotypes analyzed were UAS-mito-QC/+;nSyb-GAL4/+ (adult brain), 
UAS-mito-QC/+;TH-GAL4/+ (DA neurons), and Mef2-GAL4/UAS-mito-QC 
(adult and pupal muscle). Bars, 10 µm.
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or parkin has revealed robust loss of DA neurons (Shin et al., 2011; 
Lee et al., 2017). The authors propose that in germline knockouts 
an unknown mechanism is induced during development that com-
pensated for loss of PINK1/parkin. One possibility that would fit 
this scenario is induction of an alternative mitophagy pathway or 
up-regulation of other mitochondrial quality-control processes. 
Clearly, more needs to be learned about the complex regulatory 
mechanisms governing mitochondrial turnover under physio-
logical conditions, and our Drosophila model offers an excellent 
system to genetically address these mechanisms.
Another obvious interpretation of the current findings is that 
basal mitophagy may reflect a distinct homeostatic mechanism 
from that in which PINK1/parkin function. Indeed, whether the 
observed basal mitophagy is operating as a quality control mech-
anism or some other homeostatic process, such as maintenance 
of mitochondrial levels, is unknown. As previously described, 
the majority of studies analyzing PINK1/parkin mitophagy have 
used exogenous stressors and parkin overexpression, leaving 
it unclear what, if any, physiological stimuli provoke the same 
PINK1/parkin response. Supporting the requirement for a “sec-
ond hit,” DA neurons become selectively vulnerable to loss of par-
kin when mitochondrial DNA mutations are elevated (Pickrell 
et al., 2015). We have not yet systematically assessed the kinet-
ics of these mitophagy reporters, but we note that the observed 
mitolysosomes have not been detectably dynamic within the 
range 10–15 min of live imaging. Our primary motivation was to 
Figure 4. Basal mitophagy is minimally affected 
in Pink1 mutants. Confocal microscopy analysis of 
mito-QC reporter in Pink1B9 mutant larval epidermis and 
CNS, adult brain (2 d old), DA neurons at 2 and 30 d old, 
and adult flight muscle (2 d old), as indicated. Mitoly-
sosomes are evident as GFP-negative/mCherry-positive 
(red-only) puncta. Bars, 10 µm. Charts show quantifi-
cation of mitolysosomes and show mean ± SD of n = 6 
animals. Number of cells analyzed: epidermis, WT = 29 
cells, Pink1B9 = 29 cells; larval CNS, WT = 28 cells, Pink1B9 
= 26 cells; adult brain, WT = 74 cells, Pink1B9 = 66 cells; 
DA neurons 2 d, WT = 100 cells, Pink1B9 = 54 cells and 30 
d, WT = 78 cells, Pink1B9 = 82 cells. Quantification of WT 
control samples is the same as shown in Figs. 1 and 5. 
Statistical significance determined by Welch’s t test; ns, 
nonsignificant. Genotypes analyzed were PinkB9/Y;da-
GAL4/UAS-mito-QC (epidermis and larval CNS), 
PinkB9/Y;UAS-mito-QC/+;nSyb-GAL4/+ (adult brain), 
PinkB9/Y;UAS-mito-QC/+;TH-GAL4/+ (DA neurons), and 
PinkB9/Y;Mef2-GAL4/UAS-mito-QC (adult muscle).
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analyze physiological, basal mitophagy but it may be informative 
to assess the feasibility of monitoring stress- or toxin-induced 
mitophagy in vivo. It is possible that loss of parkin or Pink1 may 
slow the kinetics of this accelerated process but the timescales 
involved (10–24 h in cell culture) may still be too challenging for 
in vivo studies. A more targeted stimulus such as light induced 
reactive oxygen species generation may be more amenable (Yang 
and Yang, 2013; Ashrafi et al., 2014).
Growing evidence indicates that PINK1/parkin-mediated 
turnover of mitochondrial components may occur in a piecemeal 
fashion. For instance, multiple studies have described the selective 
targeting of portions of mitochondria for turnover (Hämäläinen et 
al., 2013; Yang and Yang, 2013; McLelland et al., 2014, 2016; Burman 
et al., 2017), a process likely occurring via so-called mitochondria- 
derived vesicles (Sugiura et al., 2014). That selective degradation of 
mitochondrial components may also occur in vivo is supported by 
compelling evidence using a mass spectrometric method to analyze 
isotope labeled mitochondrial protein turnover in flies (Vincow et 
al., 2013). It is possible that the current microscopy approach for the 
reporters described here is not sufficient to detect mitochondrial 
component turnover on this scale and so we may miss this aspect of 
Pink1/parkin-dependent quality control. In light of this, it is clear 
that further work is needed to define the conditions in which PINK1 
and parkin promote mitochondrial homeostasis. Notably, it will be 
important to determine the nature of physiological signals trigger-
ing PINK1/parkin mitochondrial turnover. The mitophagy reporter 
lines described here provide new model systems for studying phys-
iological mitophagy and can be potentially used for screening for 
novel regulators. Greater insights into the physiological function 
of PINK1/parkin-mediated mitochondrial homeostasis will allow 
a clearer understanding of the pathogenic causes of PD and thus a 
better prospect for more rational therapeutic interventions.
Figure 5. Basal mitophagy is minimally 
affected in parkin mutants. Confocal micros-
copy analysis of mito-QC reporter in park25 larval 
epidermis and CNS, DA neurons at 2 and 30 d old, 
and adult flight muscle (2 d old), as indicated. 
Mitolysosomes are evident as GFP-negative/
mCherry-positive (red-only) puncta. Bars, 10 µm. 
Charts show quantification of mitolysosomes and 
show mean ± SD of n = 6 animals. Quantification 
of WT control samples is the same as shown in 
Figs. 1 and 4. Number of cells analyzed: epider-
mis, WT = 29 cells, park25 = 30 cells; larval CNS, 
WT = 28 cells, park25 = 31 cells; DA neurons 2 d, 
WT = 100 cells, park25 = 69 cells and 30 d, WT 
= 78 cells, park25 = 83 cells. Statistical signif-
icance determined by Welch’s t test; ns = non-
significant. Genotypes analyzed were park25,da-
GAL4/park25,UAS-mito-QC (epidermis and larval 
CNS), UAS-mito-QC; park25,TH-GAL4/park25 (DA 
neurons), and park25,Mef2-GAL4/park25,UAS-
mito-QC (adult muscle).
Lee et al. 
Basal mitophagy is not affected by loss of Pink1 or parkin




Drosophila stocks, husbandry, and locomotor assay
Flies were raised under standard conditions at 25°C on food con-
sisting of agar, cornmeal, molasses, propionic acid, and yeast in 
a 12-h:12-h light/dark cycle. Pink1B9 mutants were a gift from 
J. Chung (Seoul National University, Seoul, South Korea; Park et 
al., 2006), and the park25 mutants have been described previously 
(Greene et al., 2003). The following strains were obtained from 
the Bloomington Drosophila Stock Center (RRID: SCR _006457): 
da-GAL4 (RRID: BDSC _55850), nSyb-GAL4 (RRID: BDSC _68222), 
Mef2-GAL4 (RRID: BDSC _27390), Atg5-RNAi (RRID: BDSC 
_34899), and TH-GAL4 (RRID: BDSC _8848). In locomotor assays, 
climbing (negative geotaxis assay) and flight ability was assessed 
as previously described, with minor modifications (Greene et al., 
2003). Transgenic expression was induced by da-GAL4, and adult 
male flies were tested 1–3 d after eclosion. Because X chromosome 
nondisjunction is present in multiple balanced Pink1B9 mutant 
stocks, correct genotypes were determined by either combining 
paternal animals with X chromosome markers or by PCR-based 
genotyping of discarded tissue after dissection. For deferiprone 
treatment, mito-QC– or mt-Keima–expressing animals were 
raised on normal food dosed with deferiprone (catalog number 
D1720; LKT Laboratories) to a final concentration of 65 µM.
Transgenic line construction
A plasmid containing the mito-QC sequence was obtained 
from I. Ganley (University of Dundee, Dundee, Scotland, UK) 
through the Medical Research Council Protein Phosphorylation 
and Ubiquitylation Unit Reagents and Services facility (College 
of Life Sciences, University of Dundee, Scotland; pBabe.hygro-
mCherry-GFP FIS 101–152(end) [DU40799]; Allen et al., 2013). 
PCR primers containing EcoRI and XbaI restriction sites were 
used to amplify mito-QC, and after restriction digestion and puri-
fication by standard methods, mito-QC was cloned into comple-
mentary sites in a pUAST.attB transgenesis vector. Constructs 
were verified by sequencing before sending for transgenesis by 
BestGene. UAS-mito-QC was integrated into attP16 and attP2 
sites and verified by PCR. Several transformant lines were tested 
for consistency before selecting a single line of each integration 
site for further study.
mt-Keima (Katayama et al., 2011) was amplified and cloned 
from mt-Keima (h)-pIND(SP1) plasmid into Drosophila expres-
sion vector pUASt. pUASt-mt-Keima construct was injected and 
recombined in w1118 fly embryos at BestGene. Four independent 
UAS-mt-Keima strains were selected: UAS-mt-Keima M7 (II), 
UAS-mt-Keima M3 (II), UAS-mt-Keima M2 (III), and UAS-mt-
Keima M4 (III) based on detection of fluorescent mt-Keima signal 
in larval eyes by crossing them with GMR-GAL4. UAS-mt-Keima 
M2 flies were genetically recombined with Tub-GAL4/TM3 (III) 
flies to finally generate Tub-GAL4, UAS-mt-Keima M2/TM3.
Antibodies and dyes
The following antibodies and dyes were used: ATP5A (catalog 
number ab14748, RRID: AB _301447; 1:500; Abcam), Actin (cat-
alog number MAB1501, RRID: AB _2223041; 1:5,000; Millipore), 
GFP (catalog number ab290, RRID: AB _303395; 1:2,000; Abcam), 
DsRed (catalog number 632496, RRID: AB _10013483; 1:1,000; 
Clontech Laboratories), Keima-Red (catalog number M126-3, 
RRID: AB _10210643; 1:1,000; MBL International), α-Tubulin (cat-
alog number T6793, RRID: AB _477585; 1:5,000; Sigma-Aldrich), 
and 500 nM LysoTracker Deep Red (L12492; Invitrogen). The 
following secondary antibodies were used for immunoblotting: 
anti-rabbit HRP (catalog number G-21234, RRID: AB _2536530; 
1:10,000; Thermo Fisher Scientific), anti-mouse HRP (catalog 
number ab67891, RRID: AB _1140250; 1:10,000; Abcam). The fol-
lowing secondary antibody were used for immunofluorescence: 
anti-mouse AF647 (catalog number A-21235, RRID: AB _2535804; 
1:200; Thermo Fisher Scientific).
Immunoblotting
Protein samples isolated from whole adult fly were prepared in 
lysis buffer (50 mM Tris·HCl, 150 mM NaCl, 10% [vol/vol] glyc-
erol, 1% Triton X-100, 10 mM N-ethylmaleimide, 2 mM EGTA, 
1 mM, MgCl2, 50 µM MG-132, and protease inhibitor mixture; 
Roche), resolved by SDS-PAGE using 12% precast gels (Bio-Rad), 
and transferred onto nitrocellulose membrane (Bio-Rad) using 
a Bio-Rad Transblot Transfer Apparatus. Membranes were 
blocked with 5% skimmed milk in TBS with 0.1% Tween-20 for 
1 h at RT and probed with the appropriate primary antibodies 
diluted in the blocking solution overnight at 4°C. Membranes 
were washed repeatedly in TBS with 0.1% Tween-20, and then 
the appropriate HRP-conjugated secondary antibodies (Dako) 
were incubated for 1  h at RT. Detection was achieved with 
ECL-Prime detection kit (Amersham). As a loading control, 
membranes were incubated with anti–α-Tubulin or anti–Actin 
antibodies for 1 h at RT.
Immunohistochemistry and sample preparation
For immunostaining of mito-QC and mt-Keima, larval epider-
mis or adult flight muscle were dissected in PBS and fixed in 4% 
formaldehyde, pH 7.0, for 30 min, permeabilized in 0.3% Triton 
X-100 for 30 min, and blocked with 0.3% Triton X-100 plus 1% 
bovine serum albumin in PBS for 1 h at RT. Tissues were incubated 
with ATP5A antibody diluted in 0.3% Triton X-100 plus 1% bovine 
serum albumin in PBS overnight at 4°C, rinsed three times 10 min 
with 0.3% Triton X-100 in PBS, and incubated with the appropri-
ate fluorescent secondary antibodies for 2 h at RT. The tissues were 
washed twice in PBS and mounted on slides using Prolong Dia-
mond Antifade mounting medium (Thermo Fischer Scientific).
For mitolysosome analysis of mito-QC, tissues were dissected 
in PBS and fixed in 4% formaldehyde, pH 7.0, for 30 min, rinsed in 
PBS, mounted in Prolong Diamond Antifade mounting medium 
(Thermo Fischer Scientific), and generally imaged the next day. 
For mitolysosome analysis of mt-Keima, larvae were dissected 
and mounted in Prolong Diamond Antifade mounting medium 
(Thermo Fischer Scientific) for immediate live imaging. Tissues 
were imaged via sequential excitations (458 nm, green; 561 nm, 
red) being captured at 578- to 638-nm emission range.
LysoTracker assay
Larvae were dissected in PBS. The epidermal cells were stained 
for 2 min with LysoTracker Deep Red diluted in PBS (final con-
centration of 500 nM). Samples were mounted in PBS immedi-
ately visualized by confocal microscopy (live imaging).
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Fluorescence imaging was conducted using a Zeiss LSM 880 con-
focal microscope equipped with Nikon Plan-Apochromat 40×/1.3 
NA and 63×/1.4 NA oil immersion objectives or an Andor Drag-
onfly spinning disk confocal microscope equipped with a Nikon 
Plan-Apochromat 100×/1.45 NA oil immersion objective. Z-stacks 
were acquired at 0.5-µm steps.
Image analysis and quantification
Confocal images were processed using Fiji (ImageJ) software (RRID: 
SCR _002285) for figure presentation. For quantification of mitolyso-
somes, spinning disk microscopy–generated images were processed 
using Imaris (version 9.0.2) analysis software (BitPlane; RRID: SCR 
_007370) to identify and count individual red-only puncta. The GFP 
and mCherry signals were adjusted to reduce background noise 
and retain only the distinct mitochondria network and red puncta, 
respectively. A surface rendered 3D structure corresponding to the 
mitochondria network was generated using the GFP signal. This 
volume was subtracted from the red channel to retain the mCherry 
signal that did not colocalize with the GFP-labeled mitochondria 
network. The mitolysosome puncta were selected according to their 
intensity and an estimated size of 0.5 µm diameter, previously mea-
sured with Imaris. Additionally, the puncta were filtered with a min-
imum size cutoff of 0.2 µm diameter. The remaining puncta were 
counted as the number of mitolysosomes.
Epidermal cells and larval CNS soma were analyzed individu-
ally where discrete cells could be distinguished. For DA neurons 
and adult CNS soma, small groups of cells were analyzed together 
and a mean score calculated per cell.
The mean number of mitolysosomes per cell was calculated 
per animal. Data points in the quantification charts show mean 
mitolysosomes per cell for individual animals, where n = 6 ani-
mals for each condition.
Statistical analysis
For behavioral analyses, a Kruskal–Wallis nonparametric test 
with Dunn’s post-hoc correction for multiple comparisons was 
used. The number of mitolysosomes was analyzed by Welch’s t 
test. Analyses were performed using GraphPad Prism 7 software 
(RRID: SCR _002798).
Online supplemental material
Fig. S1 shows that expression of mito-QC and mt-Keima is benign 
in Drosophila. Fig. S2 shows mitolysosome quantification work-
flow for larval epidermis (mito-QC only). Fig. S3 shows mitoly-
sosome analysis with mt-Keima in Pink1 mutant larval tissues.
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